Relationship of Left Ventricular Size to Left Atrial and Left Atrial Appendage Size in Sinus Rhythm Patients with Dilated Cardiomyopathy
Aurora Bakalli, Ljubica Georgievska-Ismail, Nebi Musliu, Dardan Koçinaj, Zaim Gashi, Nexhmi Zeqiri
Acta Inform Med. 2012; 20(2): 99-102
Introduction: Thromboembolic events are a frequent cause of mortality in patients with congestive heart failure. The aim of or study was to evaluate the relationship of left ventricular end diastolic diameter (LVEDD) to left atrial (LA) size and left atrial appendage (LAA) size in patients with dilated cardiomyopathy in sinus rhythm, as well as to determine the prevalence of thrombi in LV and LA/LAA. Methods: This was a prospective cross-sectional study, conducted from December 2009 until December 2011. The study included 95 patients with dilated cardiomyopathy in sinus rhythm. Patients with swallowing problems, acute myocardial infarction, atrial fibrillation/flatter, severe systolic dysfunction, and/or patients who were taking oral anticoagulation therapy were excluded. Results: Mean patient age was 58.6 ± 12.2 years and 68.4% were men. Mean LVEDD of our population was 66.5 ± 6.5 mm, while mean LA atrium, LA volume and LAA maximal area were 46 ± 5.1 mm, 87.2 ± 38.7 cm3 and 4.7 ± 1.2 cm2, respectively. LA diameter (p<0.001) and LAA maximal area (p=0.01) showed to be independent predictors of LV size. LV thrombus was detected in 13 (13.7%) patients, while LAA thrombus in 46 (48.4%) patients of our study population. : Conclusions: In conclusion, dilated LV size is associated with enlarged LA and LAA size. On the other hand, dilation of LV, LA and LAA is related to high prevalence of left chamber cardiac thrombi.
1. WHO/ISFC. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 1980; 44: 672-673.
2. Griffith GC, Stragnell R, Levinson DC et al. Study of beneficial effects of anticoagulation therapy in congestive heart failure. Ann Intern Med. 1952; 37: 867-887.
3. Lang MR, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18(12): 1440-1463.
4. Flachskampf FA, Decoodt P, Fraser AG, Daniel WG, Roelandt JR. TC for the Subgroup on Transoesophageal Echocardiography and Valvular Heart Disease, on behalf of the Working Group on Echocardiography of the European Society of Cardiology. Guidelines from the working group: Recommendations for performing transoesophageal Echocardiography. Eur J Echocardiography. 2001; 2: 8-21.
5. Dittrich HC, Perace LA, Asinger RW, et al. Left Atrial Diameter In Nonvalvular Atrial Fibrillation: An Echocardiographic Study. Am Heart J. 1999; 137(3): 494-499.
6. Al-Saddy NM, Obel OA, Camm AJ. Left Atrial Appendage: Structure, Function, and role in thromboembolism. Heart. 1999; 82: 547-555.
7. Bakalli A, Kamberi L, Pllana E, Zahiti B, Dragusha G, Brovina A. The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy. Turk Kardiyol Dern Ars 2010; 38(2): 90-94.
8. Gottdiener JS, Gay JA, VanVoorhees L, Di Bianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol. 1983; 52: 1281-1285.
9. Ciaccheri M, Castelli G, Cecchi F, et al. Lack of correlation between intracavitary thrombosis detected by cross-sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J. 1989; 62: 26-29.
10. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995; 92: 835-841.
11. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke. 2003; 34: 2380-2384.
12. Nagarajarao SH, Penman DA, Taylor AH, Mosley HT, et al. The Predictive Value of Left Atrial Size for Incident Ischemic Stroke and All-Cause Mortality in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 2008; 39; 2701-2706.
13. Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation. 1991 Jul; 84(1): 223-231.
14. Kato H, Nakanishi M, Maekawa N, Ohnishi T, Yamamoto M. Evaluation of Left Atrial Stasis in Patients with Atrial Fibrillation Using Transoesophageal Echocardiography with an intravenous albumin-contrast agent. Am J of Cardiol. 1996; 78: 365-369.
15. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboemblism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med. 1992; 116: 6-12.